Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K. American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2010;28(5):893–901.
U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005;143(5):355–61.
ACOG committee opinion. Breast-ovarian cancer screening. Number 239. August 2000. American College of Obstetricians and Gynecologists. Committee on genetics. Int J Gynaecol Obstet 2001, 75(3):339–340.
American Society of Clinical Oncology policy. Statement update: genetic testing for cancer susceptibility. J Clin Oncol. 2003;21(12):2397–406.
The National Comprehensive Cancer Network Clinical Practice Guidelines. in Oncology, editor [http://www.nccn.org/professionals/physician_gls/f_guidelines.asp].
Bradbury AR, Patrick-Miller L, Domchek S. Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencing. Genet Med. 2015;17(2):97–8.
Domchek SM, Bradbury A, Garber JE, Offit K, Robson ME. Multiplex genetic testing for cancer susceptibility: out on the high wire without a net? J Clin Oncol. 2013;31(10):1267–70.
Bradbury AR, Patrick-Miller L, Egleston B, Domchek S, Olopade O, Hall M, Daly M, Fleisher L, Grana G, Ganschow P et al. Utilization and patient reported outcomes of clinical multi-gene panel testing for cancer susceptibility in the multi-center COGENT study [abstract]. American Society of Human Genetics Annual Meeting. 2016.
Robson ME, Bradbury AR, Arun B, Domchek SM, Ford JM, Hampel HL, et al. American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2015;33(31):3660–7.
Bradbury AR, Patrick-Miller LJ, Egleston BL, Domchek SM, Olopade OI, Hall MJ, Daly MB, Fleisher L, Grana G, Ganschow P et al. Utilization and patient reported outcomes of clinical multi-gene panel testing for cancer susceptibility in the multi-center COGENT study [Submitted Abstract]. American Society of Human Genetics, 2016 2016.
Pyeritz RE. The coming explosion in genetic testing–is there a duty to recontact? N Engl J Med. 2011;365(15):1367–9.
Cheon JY, Mozersky J, Cook-Deegan R. Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come? Genome Med. 2014;6(12):121.
Murray ML, Cerrato F, Bennett RL, Jarvik GP. Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. Genet Med. 2011;13(12):998–1005.
Chen MA, Hollenberg JP, Michelen W, Peterson JC, Casalino LP. Patient care outside of office visits: a primary care physician time study. J Gen Intern Med. 2011;26(1):58–63.
Farber J, Siu A, Bloom P. How much time do physicians spend providing care outside of office visits? Ann Intern Med. 2007;147(10):693–8.
Schwartz MD, Valdimarsdottir HB, Peshkin BN, Mandelblatt J, Nusbaum R, Huang AT, et al. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol. 2014;32(7):618–26.
Bradbury AR, Egleston BL, Patrick-Miller LJ, Rustgi N, Brandt A, Brower J, et al. Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1/2 negative patients. Clin Genet. 2020;97(4):601–9.
Richter S, Haroun I, Graham TC, Eisen A, Kiss A, Warner E. Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling. Annals Oncology: Official J Eur Soc Med Oncol / ESMO. 2013;24(Suppl 8):viii69–74.
Esplen MJ, Wong J, Aronson M, Butler K, Rothenmund H, Semotiuk K, et al. Long-term psychosocial and behavioral adjustment in individuals receiving genetic test results in Lynch syndrome. Clin Genet. 2015;87(6):525–32.
Peipins LA, Dasari S, Viox MH, Rodriguez JL. Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch syndrome. Breast Cancer Res Treat. 2024;208(1):19–27.
Lautz Z, Kautz-Freimuth S, Shukri A, Redaèlli M, Rhiem K, Schmutzler R, et al. Predictors of knowledge and knowledge gain after decision aid use among women with BRCA1/2 pathogenic variants. Patient Educ Couns. 2024;124:108248.
Mooney R, Wu YP, Kehoe K, Volkmar M, Kohlmann W, Koptiuch C, Kaphingst KA. Experiences of patients and family members with follow-up care, information needs and provider support after identification of Lynch syndrome. Hered Cancer Clin Pract. 2023;21(1):28.
Gray SW, Martins Y, Feuerman LZ, Bernhardt BA, Biesecker BB, Christensen KD, et al. Social and behavioral research in genomic sequencing: approaches from the clinical sequencing exploratory research consortium outcomes and measures working group. Genet Med. 2014;16(10):727–35.
Chung WK, Brothers K, Bradbury A, Chanprasert S, Orlando L, Torkamani A, et al. Genomic medicine implementation protocols in the PhenX toolkit: tools for standardized data collection. Genet Med. 2021;23(9):1783–8.
Madlensky L, Trepanier AM, Cragun D, Lerner B, Shannon KM, Zierhut H. A rapid systematic review of outcomes studies in genetic counseling. J Genet Couns. 2017;26(3):361–78.
Peter M, Hammond J, Sanderson SC, Gurasashvili J, Hunter A, Searle B, Patch C, Chitty LS, Hill M, Lewis C. Knowledge, attitudes and decision regret: a longitudinal survey study of participants offered genome sequencing in the 100,000 genomes project. Eur J Hum Genet. 2023;31(12):1407–13.
Kilbride MK, Egleston BL, Hall MJ, Patrick-Miller LJ, Daly MB, Ganschow P, et al. Longitudinal follow-up after telephone disclosure in the randomized COGENT study. Genet Med. 2020;22(8):1401–6.
Culver JO, Ricker CN, Bonner J, Kidd J, Sturgeon D, Hodan R, Kingham K, Lowstuter K, Chun NM, Lebensohn AP, et al. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients. Cancer. 2021;127(8):1275–85.
Carlsson L, Bedard PL, Kim RH, Metcalfe K. Psychological distress following multi-gene panel testing for hereditary breast and ovarian cancer risk. J Genet Counsel. 2024. https://doi.org/10.1002/jgc4.1940.
Carlsson L, Thain E, Gillies B, Metcalfe K. Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature. Hered Cancer Clin Pract. 2022;20(1):25.
Mighton C, Shickh S, Uleryk E, Pechlivanoglou P, Bombard Y. Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis. Genet Med. 2021;23(1):22–33.
Meiser B, Quinn VF, Mitchell G, Tucker K, Watts KJ, Rahman B, Peate M, Saunders C, Geelhoed E, Gleeson M, et al. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history. Eur J Hum Genet. 2018;26(7):972–83.
Jacobs C, Rawson R, Campion C, Caulfield C, Heath J, Burton C, et al. Providing a community-based cancer risk assessment service for a socially and ethnically diverse population. Fam Cancer. 2007;6(2):189–95.
Buchanan AH, Rahm AK, Williams JL. Alternate service delivery models in cancer genetic counseling: a mini-review. Front Oncol. 2016;6:120.
Institute of Medicine. Crossing the quality chasm: A new health system for the 21st century. Washington D.C.: National Academies; 2001.
Epstein RM, Fiscella K, Lesser CS, Stange KC. Why the nation needs a policy push on patient-centered health care. Health Aff. 2010;29(8):1489–95.
Ammenwerth E, Schnell-Inderst P, Hoerbst A. The impact of electronic patient portals on patient care: a systematic review of controlled trials. J Med Internet Res. 2012;14(6):e162.
Amerincans’. Internet Access: 2000–2015.
Liederman EM, Morefield CS. Web messaging: a new tool for patient-physician communication. J Am Med Inf Association: JAMIA. 2003;10(3):260–70.
Lin CT, Wittevrongel L, Moore L, Beaty BL, Ross SE. An internet-based patient-provider communication system: randomized controlled trial. J Med Internet Res. 2005;7(4):e47.
Delbanco T, Sands DZ. Electrons in flight–e-mail between doctors and patients. N Engl J Med. 2004;350(17):1705–7.
Steitz BD, Turer RW, Lin C-T, MacDonald S, Salmi L, Wright A, Lehmann CU, Langford K, McDonald SA, Reese TJ, et al. Perspectives of patients about immediate access to test results through an online patient portal. JAMA Netw Open. 2023;6(3):e233572–233572.
Murray E, Burns J, See TS, Lai R, Nazareth I. Interactive health communication applications for people with chronic disease. Cochrane Database Syst Rev 2005(4):CD004274.
Borosund E, Cvancarova M, Moore SM, Ekstedt M, Ruland CM. Comparing effects in regular practice of e-communication and web-based self-management support among breast cancer patients: preliminary results from a randomized controlled trial. J Med Internet Res. 2014;16(12):e295.
McCarrier KP, Ralston JD, Hirsch IB, Lewis G, Martin DP, Zimmerman FJ, et al. Web-based collaborative care for type 1 diabetes: a pilot randomized trial. Diabetes Technol Ther. 2009;11(4):211–7.
Kruse CS, Bolton K, Freriks G. The effect of patient portals on quality outcomes and its implications to meaningful use: a systematic review. J Med Internet Res. 2015;17(2):e44.
Goldzweig CL, Orshansky G, Paige NM, Towfigh AA, Haggstrom DA, Miake-Lye I, Beroes JM, Shekelle PG. Electronic patient portals: evidence on health outcomes, satisfaction, efficiency, and attitudes: a systematic review. Ann Intern Med. 2013;159(10):677–87.
McGeady D, Kujala J, Ilvonen K. The impact of patient-physician web messaging on healthcare service provision. Int J Med Inform. 2008;77(1):17–23.
Kruse CS, Argueta DA, Lopez L, Nair A. Patient and provider attitudes toward the use of patient portals for the management of chronic disease: a systematic review. J Med Internet Res. 2015;17(2):e40.
Zhou YY, Kanter MH, Wang JJ, Garrido T. Improved quality at Kaiser permanente through e-mail between physicians and patients. Health Aff. 2010;29(7):1370–5.
Ye J, Rust G, Fry-Johnson Y, Strothers H. E-mail in patient-provider communication: a systematic review. Patient Educ Couns. 2010;80(2):266–73.
Ruland CM, Andersen T, Jeneson A, Moore S, Grimsbo GH, Borosund E, Ellison MC. Effects of an internet support system to assist cancer patients in reducing symptom distress: a randomized controlled trial. Cancer Nurs. 2013;36(1):6–17.
Yun YH, Lee KS, Kim YW, Park SY, Lee ES, Noh DY, et al. Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol. 2012;30(12):1296–303.
Tuil WS, Verhaak CM, Braat DD, de Vries Robbe PF, Kremer JA. Empowering patients undergoing in vitro fertilization by providing internet access to medical data. Fertil Steril. 2007;88(2):361–8.
Navarro-Sainz A, Huda S, Bectarte R. Unified patient portal: engaging patients throughout the genetic testing journey. DRS2024: 2024; Boston. Design Reserach Society; 2024. pp. 23–8.
Burke W, Khoury MJ, Stewart A, Zimmern RL. The path from genome-based research to population health: development of an international public health genomics network. Genet Med. 2006;8(7):451–8.
Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA. 2008;299(11):1320–34.
Burgess MM. Beyond consent: ethical and social issues in genetic testing. Nat Rev Genet. 2001;2(2):147–51.
Leventhal H, Benyamini Y, Brownlee S, Diefenbach M, Leventhal EA, Patrick-Miller L. Perceptions of Health and Illness: Current Research and Applications. In: Petrie KJ, Weinman JA, editors. Illness representations: theoretical foundations. Amsterdam: Harwood; 1997. p. 19–46.
Cameron L, Leventhal EA. Symptom representations and affect as determinants of care seeking in a community-dwelling, adult sample population. Health Psychol. 1993;12:171–9.
Patrick-Miller L, Kelly K, Toppmeyer D, Leventhal H, Much J, Baron J, Schwalb M. Breast cancer screening behaviors and perceived control in individuals interested in testing for BRCA1/2 mutations [Abstract]. In: American Society of Clinical Oncology: 2001; 2001.
Weinman J, Petrie K, Sharpe N. Causal attributions in patients and spouses following first-time myocardial infarction and subsequent lifestyle changes. Br J Health Psychol. 2000;5:263–73.
Zimmerman RS, Safer MA, Leventhal H, Baumann LJ. The effects of health information in a worksite hypertension screening program. Health Educ Q. 1986;13:261–80.
Kelly K, Leventhal H, Andrykowski M, Toppmeyer D, Much J, Dermody J, et al. Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Psycho-oncol. 2005;14(1):34–48.
Park D. Self-regulation and control of rheumatic disorders. New York: Wiley; 1994.
Kelly KM, Ferketich AK, Sturm AC, Porter K, Sweet K, Kemp K, et al. Cancer risk and risk communication in urban, lower-income neighborhoods. Prev Med. 2009;48(4):392–6.
Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217–26.
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.
Stevenson L, Ball S, Haverhals LM, Aron DC, Lowery J. Evaluation of a national telemedicine initiative in the veterans health administration: factors associated with successful implementation. J Telemed Telecare. 2016. https://doi.org/10.1177/1357633X16677676.
Kirk MA, Kelley C, Yankey N, Birken SA, Abadie B, Damschroder L. A systematic review of the use of the consolidated framework for implementation research. Implement Sci. 2016;11:72.
Damschroder LJ, Lowery JC. Evaluation of a large-scale weight management program using the consolidated framework for implementation research (CFIR). Implement Sci. 2013;8:51.
Trieu PF, McLeod D, Schweickert B, Gutstein K, Egleston L, Domchek B, Fleisher S, Wagner L, Wen L, Cacioppo KY, Ebrahimzadeh C, Falcone JE, Langer D, Wood C, Karpink E, Selmani K, Bradubry E. AR: Developing the mycancergene digital health portal to improve patients’ Understanding of germline cancer genetic test results: development, user, and usability testing study. JMIR Formative Research Forthcoming.
Underhill-Blazey M, Stopfer J, Chittenden A, Nayak MM, Lansang K, Lederman R, et al. Development and testing of the knowgene scale to assess general cancer genetic knowledge related to multigene panel testing. Patient Educ Couns. 2019;102(8):1558–64.
Stover PJ, Harlan WR, Hammond JA, Hendershot T, Hamilton CM. PhenX: a toolkit for interdisciplinary genetics research. Curr Opin Lipidol. 2010;21(2):136–40.
Eckert SL, Katzen H, Roberts JS, Barber M, Ravdin LD, Relkin NR, et al. Recall of disclosed Apolipoprotein E genotype and lifetime risk estimate for alzheimer’s disease: the REVEAL study. Genet Med. 2006;8(12):746–51.
Bradbury AR, Patrick-Miller L, Long J, Powers J, Stopfer J, Forman A, et al. Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility. Genet Med. 2015;17(6):485–92.
Baum G, Basen-Engquist K, Swartz MC, Parker PA, Carmack CL. Comparing PROMIS computer-adaptive tests to the brief symptom inventory in patients with prostate cancer. Qual Life Res. 2014;23(7):2031–5.
Wagner LI, Schink J, Bass M, Patel S, Diaz MV, Rothrock N, et al. Bringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer care. Cancer. 2015;121(6):927–34.
Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, et al. A brief assessment of concerns associated with genetic testing for cancer: the multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychol. 2002;21(6):564–72.
Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med. 1979;41(3):209–18.
Sundin EC, Horowitz MJ. Impact of event scale: psychometric properties. Br J Psychiatry. 2002;180:205–9.
Hamilton JG, Lobel M, Moyer A. Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol. 2009;28(4):510–8.
Vickberg SM, Bovbjerg DH, DuHamel KN, Currie V, Redd WH. Intrusive thoughts and psychological distress among breast cancer survivors: global meaning as a possible protective factor. Behav Med. 2000;25(4):152–60.
Croyle RT, Smith KR, Botkin JR, Baty B, Nash J. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol. 1997;16(1):63–72.
Lloyd S, Watson M, Waites B, Meyer L, Eeles R, Ebbs S, Tylee A. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Br J Cancer. 1996;74(3):482–7.
Meiser B, Butow PN, Barratt AL, Schnieden V, Gattas M, Kirk J, et al. Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Educ Couns. 2001;44(3):215–25.
Patrick-Miller L, Egleston BL, Daly M, Stevens E, Fetzer D, Forman A, et al. Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results. Patient Educ Couns. 2013;93(3):413–9.
Bradbury AR, Patrick-Miller LJ, Egleston BL, DiGiovanni L, Brower J, Harris D, et al. Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing. Genet Med. 2016;18(1):25–33.
Bradbury AR, Patrick-Miller LJ, Egleston BL, Hall MJ, Domchek SM, Daly MB, et al. Randomized noninferiority trial of telephone vs in-person disclosure of germline cancer genetic test results. J Natl Cancer Inst. 2018. https://doi.org/10.1093/jnci/djy015.
Botkin JR, Smith KR, Croyle RT, Baty BJ, Wylie JE, Dutson D, Chan A, Hamann HA, Lerman C, McDonald J, et al. Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet. 2003;118(3):201–9.
King ES, Rimer BK, Trock B, Balshem A, Engstrom P. How valid are mammography self-reports? Am J Public Health. 1990;80(11):1386–8.
Kotsopoulos J, Narod SA. Towards a dietary prevention of hereditary breast cancer. Cancer Causes Control. 2005;16(2):125–38.
O’Neill SC, Kaufman E, DeMarco T, Peshkin BN, McKenna K, Shelby R, Valdimarsdottir H, Rispoli J, Schwartz MD. Changes in diet and physical activity following BRCA1/2 testing. J Psychosoc Oncol. 2008;26(3):63–80.
Emmons KM, Kalkbrenner KJ, Klar N, Light T, Schneider KA, Garber JE. Behavioral risk factors among women presenting for genetic testing. Cancer Epidemiol Biomarkers Prev. 2000;9(1):89–94.
CDC: Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system survey questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2010. http://www.cdc.gov/brfss/.
Health and Diet Survey Dietary Guidelines, Supplement. http://www.fda.gov/downloads/Food/ScienceResearch/ResearchAreas/ConsumerResearch/ucm080413.pdf
Chew LD, Griffin JM, Partin MR, Noorbaloochi S, Grill JP, Snyder A, et al. Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med. 2008;23(5):561–6.
Blake KD, Portnoy DB, Kaufman AR, Lin CJ, Lo SC, Backlund E, Cantor D, Hicks L, Lin A, Caporaso A, et al. Rationale, procedures, and response rates for the 2015 administration of nci’s health information National trends survey: HINTS-FDA 2015. J Health Communication. 2016;21(12):1269–75.
Gibbons MC, Fleisher L, Slamon RE, Bass S, Kandadai V, Beck JR. Exploring the potential of web 2.0 to address health disparities. J Health Commun. 2011;16(Suppl 1):77–89.
Sarkar U, Karter AJ, Liu JY, Adler NE, Nguyen R, Lopez A, et al. Social disparities in internet patient portal use in diabetes: evidence that the digital divide extends beyond access. J Am Med Inform Assoc. 2011;18(3):318–21.
Krull KR, McDonald A, Goodman P, et al. Impact of COVID-19 pandemic on a large cohort of adult survivors of childhood cancer. Pediatr Blood Cancer. 2021; 68e29324. https://doi.org/10.1002/pbc.29324.
Sawyer MG, Reece CE, Bowering K, Jeffs D, Sawyer AC, Peters JD, et al. Usage, adherence and attrition: how new mothers engage with a nurse-moderated web-based intervention to support maternal and infant health. A 9-month observational study. BMJ Open. 2016;6(8):e009967.
Eysenbach G, Group C-E. CONSORT-EHEALTH: improving and standardizing evaluation reports of web-based and mobile health interventions. J Med Internet Res. 2011;13(4):e126.
Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P. A multivariate technique for multiplying imputing missing values using a sequence of regression models. Surv Methodol. 2001;27(1):85–95.
Harrell FEJ. In: Regression modeling strategies. edn. New York, NY: Springer: 14–5.
Best practices transforiming quality, safety and efficacy. Electronic medical records [https://healthit.ahrq.gov/key-topics/electronic-medical-record-systems#one (Accessed 6/24/16)].
Nishimura AA, Tarczy-Hornoch P, Shirts BH. Pragmatic and ethical challenges of incorporating the genome into the electronic medical record. Curr Genet Med Rep. 2014;2(4):201–11.
Shirts BH, Salama JS, Aronson SJ, Chung WK, Gray SW, Hindorff LA, et al. CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record. J Am Med Inform Assoc. 2015. https://doi.org/10.1093/jamia/ocv065.
Ritchie MD, de Andrade M, Kuivaniemi H. The foundation of precision medicine: integration of electronic health records with genomics through basic, clinical, and translational research. Front Genet. 2015;6:104.